ERBB2 and breast carcinoma: MDA-MB-436 primary tumors were CK18 positive, EGFR positive, Her2 negative (Figure 2B), demonstrating that the NSG MDA-MB-436 xenograft tumors also retained the MDA-MB-436 cell line expression pattern of key breast cancer markers.